Gelonghui, April 26 | Rhine Biotech (002166.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 341 million yuan, up 35.07% year on year; net profit attributable to shareholders of listed companies was 267.91 million yuan, up 34.37% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 395.709 million yuan, up 372.05% year on year; basic earnings per share were 0.04 yuan.
莱茵生物(002166.SZ)：一季度净利润2679.01万元 同比增长34.37%
RheinBio (002166.SZ): Net profit of 267.901 million yuan in the first quarter increased by 34.37% year-on-year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.